Journal Article

Regenerative medicine in the treatment of specific dermatologic disorders: a systematic review of randomized controlled clinical trials

Khosravi, Mina, Keramati, Haniyeh, Zeinali, Roya, Goodarzi, Azadeh, Pour Mohammad, Arash, Jafarzadeh, Alireza

2024

Overview

Aims and objectives The aim of this study is to systematically review randomized controlled clinical trials (RCTs) studying various types of regenerative medicine methods (such as platelet-rich plasma, stromal vascular fraction, cell therapy, conditioned media, etc.) in treating specific dermatologic diseases. Rejuvenation, scarring, wound healing, and other secondary conditions of skin damage were not investigated in this study. Method Major databases, including PubMed, Scopus, and Web of Science, were meticulously searched for RCTs up to January 2024, focusing on regenerative medicine interventions for specific dermatologic disorders (such as androgenetic alopecia, vitiligo, alopecia areata, etc.). Key data extracted encompassed participant characteristics and sample sizes, types of regenerative therapy, treatment efficacy, and adverse events. Results In this systematic review, 64 studies involving a total of 2888 patients were examined. Women constituted 44.8% of the study population, while men made up 55.2% of the participants, with an average age of 27.64 years. The most frequently studied skin diseases were androgenetic alopecia (AGA) (45.3%) and vitiligo (31.2%). The most common regenerative methods investigated for these diseases were PRP and the transplantation of autologous epidermal melanocyte/keratinocyte cells, respectively. Studies reported up to 68.4% improvement in AGA and up to 71% improvement in vitiligo. Other diseases included in the review were alopecia areata, melasma, lichen sclerosus et atrophicus (LSA), inflammatory acne vulgaris, chronic telogen effluvium, erosive oral lichen planus, and dystrophic epidermolysis bullosa. Regenerative medicine was found to be an effective treatment option in all of these studies, along with other methods. The regenerative medicine techniques investigated in this study comprised the transplantation of autologous epidermal melanocyte/keratinocyte cells, isolated melanocyte transplantation, cell transplantation from hair follicle origins, melanocyte–keratinocyte suspension in PRP, conditioned media injection, a combination of PRP and basic fibroblast growth factor, intravenous injection of mesenchymal stem cells, concentrated growth factor, stromal vascular fraction (SVF), a combination of PRP and SVF, and preserving hair grafts in PRP. Conclusion Regenerative medicine holds promise as a treatment for specific dermatologic disorders. To validate our findings, it is recommended to conduct numerous clinical trials focusing on various skin conditions. In our study, we did not explore secondary skin lesions like scars or ulcers. Therefore, assessing the effectiveness of this treatment method for addressing these conditions would necessitate a separate study.

• Publisher: BioMed Central,BioMed Central Ltd,BMC
• Subject: Adult / Biomedical and Life Sciences / Biomedical Engineering and Bioengineering / Care and treatment / Cell Biology / Clinical trials / Dermatologic agents / Dermatological disorder / Dermatology / Drug therapy / Female / Fibroblast growth factors / Formulae, receipts, prescriptions / Humans / Life Sciences / Male / Management / Medical research / Medicine, Experimental / Platelet-Rich Plasma / Product development / PRP / Randomized Controlled Trials as Topic / Regenerative medicine / Regenerative Medicine - methods / Regenerative Medicine/Tissue Engineering / Review / Secondary data analysis / Skin / Skin diseases / Skin Diseases - therapy / Skin lesions / Stem cell research / Stem Cells / SVF / Systematic review / Transplantation